INCONTINENCE: The dilemma with comparing efficacy of OAB treatments
The comparative efficacy of drugs for the management of overactive bladder syndrome (OAB) remains undefined. A new indirect treatment comparison demonstrates similar efficacy of mirabegron versus several antimuscarinic drugs and onabotulinum toxin A in a number of outcome mea sures. Head-to-head trials of these agents are still required to optimize the management of patients with OAB.
Refers to Obloza, A. et al. Indirect treatment comparison (ITC) of medical therapies for an overactive bladder. Neurourol. Urodyn.http://dx.doi.org/10.1002/nau.23189 (2017)